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ABSTRACT
This current study provides information regarding the inhibition of calcium oxalate type of
kidney stones by the use of nordihydroguaiaretic acid (NDGA). Around 80% of kidney stones
found in patients are principally made of calcium oxalate and calcium phosphate. NDGA is an
antioxidant compound that is chemically extracted from the desert bush Larrea tridentata. This
work is a logical continuation of a previous research, where different concentrations of Larrea
tridentata extract were used for such inhibition. Size and morphological changes from a calcium
oxalate monohydrate (COM) structure to a calcium oxalate dihydrate (COD) structure were
previously reported.
In the current research, synthetically grown calcium oxalate crystals with and without
NDGA are analyzed by Raman and Fourier transformed infrared absorption spectroscopies. The
Raman results show that the presence of NDGA has no contribution to previously observed
morphological changes, but its presence affects the strength and bond between carbon atoms. The
presence of a strong absorption line in infrared spectrum reveals the existence of NDGA in a
sample.
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Chapter 1: INTRODUCTION
1.1 EPIDEMIOLOGY:
Kidney stone diseases, also known as urolithiasis, is a multifactorial disease caused by
accumulation of calculi in the urine that crystalize to form strong solid. This solid could go through
urinary tract resulting in irregular, very strong pain, nausea or vomiting, blood in urine, and painful
urination. Kidney stones generally have no distinct, single cause. However, several factors may
contribute to an increased risk of kidney stone formation such as hereditary, dehydration, intake
of certain diets containing high protein, sodium and sugar, obesity, and certain medical condition
(renal tubular acidosis, hyperparathyroidism, gout, cystinuria) [1]. Roughly 50 percent of patients
with history of urinary calculi have a recurrence of stone within seven year period [2]. Thus, kidney
stone or urolithiasis, or renal lithiasis, or nephrolithiasis is a multifactorial disease out of which
the primal factor is accumulation of calculi in the urine that may crystalize to form strong solid.
This solid is composed of organic or inorganic materials, which are combined with proteins.
According to stone composition, urinary stones can be classified as calcium stone, struvite stone,
uric acid stone, and some other types including xanthine stone [3]. Around 80% of kidney stones
are principally made of calcium oxalate and calcium phosphate, 10% struvite (magnesium
ammonium phosphate created amid contamination with bacteria that have enzyme urease), 9%
uric acid and rest of 1% is made of cystine or ammonium acid urate [1].
T. Alelign and B. Petros speculated that about 12% of world population has been affected
by kidney stone regardless of sex, age, and race [3]. Also, kidney stone development was
dominantly encountered in men than in women, both for an age group of 20-39 years. Calcium
oxalate is the most frequently occurring kidney stone that forms at Randall’s plague on the renal
papillary surfaces. About 12% of Indian population are expected to have urinary stones, out of
1

which half may wind up with loss of kidney functions. Nowadays, there is no medication to fix it,
as well as to avert kidney stone recurrence [4].
An overview published on U.S. National Library of Medicine reported that kidney stone
affects 1 in 11 people in the United States [4]. There it is also assessed that 600,000 Americans
will experience the ill effects of urinary stones every year. It was speculated that the prevalence of
kidney stone in the United States was 8.8%, out of which 10.6% were men and 7.1% were women.
Kidney stones were more typically reported among obese people than ordinary weighted people.
Thus, obesity and diabetes were unequivocally connected with kidney stones [5].
The research group led by Dr. Seema Jawalekar et al. collected urine samples from 100
normal people and 100 patients with kidney stone problems. They analyzed the sample
spectrophotometrically for stone inhibitors like magnesium and citrate, and for stone promoters
like calcium, uric acid, oxalate, and phosphate. This analysis showed that urinary calcium, oxalate,
and uric acid levels are significantly higher than phosphate in kidney stone patients than those for
normal people. This experiment concluded that inhibition of crystal growth has correspondence to
the presence of different concentrations of inhibitory factors [6].
Similarly, the research team at the Carl R Institute for Genomic Biology at the University
of Illinois Urbana-Champaign found that a kidney stone is made of a calcium-rich layer that is
similar to other mineralization occurring in nature. This layer can partially dissolve and regrow
again and again with the formation of kidney stone [7]. The research group led by C. John Sperati
emphasized on medication-induced crystalluria, which can result in nephrolithiasis or acute kidney
injury (AKI). They did the case presentation of 51-year-old women that was admitted in hospital
for stage 3 chronic kidney disease with nephrolithiasis. This research concluded that triamterene
related crystalline nephropathy, although uncommon, it could possibly be an under recognized
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clinical element. For differential diagnosis of AKI and nephrolithiasis, one should consider
triamterene that can significantly overlap with 2,8-DHA and oxalate[8].
The team of Geobiology revealed the dissolution of kidney stone in vivo by analyzing
fragments of CaOx kidney stones from Mayo Clinic’s patients, using a wide range of optical
microscopy (250 nm resolution). The microscopic experiments showed that a broad and rehashed
disintegration of stone happens all through the growth process of each stone. This proof stands as
an unmissable difference to the basic recognition that kidney stone don’t just break in the human
kidney. This outcome proposes different strategies for in vivo disintegration of kidney stones to
alleviate the diseases based on knowledge of physical, chemical, and organic procedures through
which minerals are deposited (i.e., various common and designed situations when
biomineralization happens) [9]. For example, another study led by S. Vaitheswori indicated that
calcium oxalate stones’ agglomerations can be inhibited by sodium hydrogen sulfide and its
metabolite thiosulphate. This inhibition makes the crystal unstable in both, the physiological buffer
and urine. This impact is ascribed to pH changes and complexing of calcium by S2O32- and SO42moiety produced by the test mixture [10].
1.2 KIDNEY STONE COMPOSITION:
As mentioned above, kidney stones are composed of various combination of compounds.
Chemical analysis of a kidney stone allows for precise determination of stone composition. The
most common types of stone formed on kidney are:
1.2.1 CALCIUM STONES:
Calcium stones occupies a lion’s share of the kidney stone. About 85% of renal stones are
composed of calcium compounds. Calcium oxalate and calcium phosphate are the most common
types, out of which, calcium oxalate is found predominantly. Patients with metabolic or hormonal
3

disorders such as renal tubular acidosis and hyperparathyroidism usually have calcium phosphate
stones. Renal calcium leak, increase level of hormones (hyperthyroidism and hypervitaminosis),
and increased intestinal absorption of calcium may increase the hypercalciuria (excess calcium in
stone), resulting in stone formation.
1.2.2 URIC ACID STONES:
Uric acid is produced due to digestion and metabolism of meat proteins. Uric acid may not
disperse if the acid level in the urine is high, thus, forming uric acid stones. About 10% of patients
with urolithiasis have this kind of stones. Using alkaline medicine such as potassium citrate and
sodium bicarbonate, these kinds of stones can be dissolved.
1.2.3 STRUVITE STONES:
These stones are formed due to urinary tract infection. The chemicals produced by bacteria
present in the urinary tract neutralize the urinary acid. As such, bacteria are enabled to grow
rapidly, thus, promoting struvite stone development. These stones are most commonly found in
women, as they are more vulnerable to urinary tract infection.
1.2.4 CYSTINE STONES:
About less than 1% of the patient with urolithiasis have these kinds of stones. Usually, they
are found in patients who are suffering from cystinuria (an inherited kidney disorder). Cystine are
formed through the coupling of two identical amino acids called cysteine. People with cystinuria
lose large amount of cystine in the urine, resulting in a rapid and fast growth of stones. These
stones are hard to teat and requires long term treatments [11][3].
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1.3 THEORY OF KIDNEY STONE FORMATION:
There are four fundamental contributing and interrelated issues to kidney stone formation:
crystal nucleation, growth and retention of crystals and particles, aggregation, and the driving force
or supersaturation of urine with respect to ions.
1.3.1 SUPERSATURATION OR THE DRIVING FORCE:
Urine is a complex mixture of water and ionic solutes that are capable of making salts. The
solution is said to be saturated if balance exist between solute and solvent. Under supersaturation
condition in urine, the formation of kidney stone is controlled by a driving force called free energy
and is expressed as
𝐴

∇𝐺 = 𝑅𝑇𝑙𝑛( 𝐴0 )
𝑖

(1.1)

where A0 and Ai are the activity at any given condition and at equilibrium condition, respectively.
T is the temperature and R is the gas constant. The activity, A, is related to the concentration C by
the activity coefficient, f, as follows:
𝐴 = 𝑓𝐶
For a given salt in urine, if

𝐴0
𝐴𝑖

(1.2)

< 1 , then ∆𝐺 < 0. This implies that the solvent is greater

than that of solute. This condition is called undersaturation. In this case, in urine, for given
conditions, the stones get dissolved.
Similarly, for a given salt, if 𝐴𝑖 = 𝐴0 , then ∆𝐺 = 0. In this case, urine is said to be
saturated. Here, no new stones will form and the old stone in urine retain itself.
Urine is said to be supersaturated, if, for a given salt, 𝐴0 > 𝐴𝑖 . In this case, ∆𝐺 > 0 and
the driving force is responsible for the growing of existing stone in the kidney.
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Precipitation does not occur if there is no stone (i.e., crystal) until and unless

𝐴0
𝐴𝑖

exceeds

the “metastable limit”. It has been suggested that new stone formation, and growth of old stones,
are possible above the metastable limit [12].
1.3.2 NUCLEATION:
Nucleation is a phenomenon when from a nucleus the crystallization process in solution
starts. Nucleation is the initial process of stone-salt precipitation. In urine, heterogeneous
nucleation (the condensation of a compound on a foreign substance) occurs in which nuclei form
on existing surfaces. The general nucleating sites in urine are urinary casts, epithelial cells, RBCs,
and other crystals. It requires high chemical pressure to form an initial nucleus, but once nucleus
is created and anchored, crystallization takes place even in a low chemical pressure. Crystallization
of CaOx crystals may increase if renal tubular cell gets injured, providing additional sites for
heterogeneous nucleation.
1.3.3 GROWTH AND RETENTION OF CRYSTALS AND PARTICLES:
There is no harm if CaOx monohydrate (COM) precipitate itself until and unless they move
spontaneously through urinary tract. There will be an issue if particles are retained and form nidus
of the stone. Here, retention is defined as a slower movement of the particles through urinary tract
than that of the flow of urine. The reason may be the size of stone being large or the particles being
attached to the renal tubules. The renal tubules, the renal pelvis, and the urinary bladder are the
cites of urinary tract where urinary stone diseases occur.
During normal flow of urine through the kidney, crystalline particles may not be big
enough to retain in pelvis or nephron. This mechanism suggests only ladder stone formation. Stone
is formed due to particle retention caused by adherence to cells or disturbed urinary flow.
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The particles formed during the processes of nucleation, crystal growth, and aggregation
could be large enough to be retained in the collecting duct. At the point where such expansive
agglomerate is retained, it will additionally accumulate organic and inorganic materials, turning
into a stone. The entire solidification might be pushed into nephron, or in the case that it is too
large in size, to move incrementally until the point when it breaks into the pelvis zone. When the
crystallite is pushed along, it might hurt the cells covering the tubules in his way to reach to the
basement membrane, where it will end up.
1.3.4 AGGREGATION:
The formation of larger particles due to accumulation of crystals that form in a free solution
is known as aggregation. Urine stones are polycrystalline aggregates. Aggregation on an existing
crystal can also occur due to a secondary nucleation of new crystals[13]. Organic matrix such as
protein, lipids, polysaccharides, and other cell-derived materials plays an important role in
aggregation [14].
1.4 ROLE OF ORGANIC MATRIX IN STONES:
Organic matrix has an important role in aggregation. Proteins comprises noteworthy
portion of organic matrix and are considered to play vital role in the growth and formation of the
kidney stone. Calculi formers are supposed to have besides the limiting factors (i.e., the inhibitors)
promoters that enhance the sizes of the crystals.
1.5 CLINICAL MANAGEMENT:
1.5.1 CLINICAL PRESENTATION:
Kidney stones are followed by pain, infection or hematuria. The classic presentation of a
kidney stone is with severe loin to groin colicky pain associated with nausea or vomiting. If the
stone is small and non-obstructing for the flow of urine, then symptoms are occasionally. In the
7

case of the entry of urinary calculi into ureter with intense obstruction, a proximal urinary tract
dilation and spasm occurs and is related to classic renal colic.
The clinical features of urinary tract stones are:
1.5.1.1 URINARY TRACT SYMPTOMS:
-

Pain as classic colicky loin to groin or renal

-

Hematuria, gross or microscopic (occurs in 90% of cases)

-

Dysuria and strangury

1.5.1.2 SYSTEMATIC SYMPTOMS:
-

Nausea or vomiting, or both (shared innervation of renal capsule and intestine)

-

Restlessness

-

Fever and chills (if associated with infection)

1.5.1.3 ASYMPTOMATIC:
-

Incidental stones (one third may become symptomatic)

1.5.2 INITIAL MANAGEMENT: The initial management contains two parts: the conservative
management and the intervention therapy.
1.5.2.1 CONSERVATIVE MANAGEMENT:
If a kidney stone present in a patient has a size smaller than 5mm then conservative
management is preferred, since for ureteric stones, 90% of them pass spontaneously through urine.
These stone take an average time between one to three weeks to pass through urine. Regular
observation within three to four weeks must be carried out in case of urgent intervention is
indicated for intractable symptoms, infection or obstruction [1].
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1.5.2.2 INTERVENTION THERAPY:
A plain kidney-ureter-bladder radiogram is used that reveals only urinary stones but not
radiolucent stones such as cystine and uric acid stones. Ultrasonography (US) or intravenous
urogram (IVU) can confirm an obstructing stone. IVU has been replaced by noncontrast spiral CT
in the diagnosis of an acute flank pain secondary to urolithiasis, being cost effective and taking
less time. Also, since CT requires a high radiation dose, it may have some health issues in a long
run. Furthermore, with the invention of extracorporeal shockwave lithotripsy (ESWL) and
advanced endoscopic technique, the treatment of kidney stone has become far less easy. Due to
advancement in these technologies, open surgical treatment of urolithiasis is rarely performed
these days. ESWL uses repeated firing of X-ray or ultrasound to break the kidney stones, which
can be located in kidney or ureter, into smaller pieces that can pass out with urine over a few
weeks. SWL does not function well on hard, large stones such as cysteine stones and a few kinds
of calcium oxalate and calcium phosphate stones.
Another method, ureteroscopy (URS), uses small telescope that passes into bladder up to
the ureter and into the kidney, so that the urologist could see the stone without incision. Once the
stone is observed, it is grabbed and removed by a small basket-like device of ureteroscopy. Some
lasers are used to break the stone if the stone is too big to be removed in a single piece.
Percutaneous nephrolithotomy (PCNL) is the method used for removal and treatment of large
kidney stones. PCNL use nephoscopy (a rigid telescope) through which an instrument is inserted
to break the stone, followed by suction of the pieces.
Open surgeries, such as laparoscopic or robotic surgery are rarely used to remove stones
[15].
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1.6 MEDICAL MANAGEMENT:
Medical management is mostly used to prevent recurrence of nephrolithiasis and it is not
very cost effective. Recurrent nephrolithiasis is defined as the most likely occurring clinical
problem in urolithiasis, which may occur within ten-year period of the first episode. Medical
prophylaxis is successful only for about 80% of patients with repetitive calcium stones [2].
1.7 TRADITIONAL MEDICINE:
After the urinary tract infection and the prostate kidney pathology, kidney stone disease is
the third most common disease that causes extraordinary agony because of the blockage of urinary
flow. Medicinal herbs are utilized in various societies and regions as a solid wellspring of common
cures. Traditional medicine survives from ancient times to modern era, and has been recognized
as the alternative medicine [16]. Mostly known traditional medicine incorporate Ayurveda,
traditional Chinese medicine, ancient Iranian medicine, traditional Korean medicine, Unani,
Islamic medicine, traditional African medicine, siddha medicine, ifa and mti [17].
United States of Agriculture defined traditional medicine as – “systems of medicine based
on cultural beliefs and practices handed down from generation to generation.” Traditional
medicine is also known as the concepts of mystical and magical rituals (spiritual therapies),
phytotherapy, and other treatments which may not be explained by modern medicine [18]. The
World Health Organization (WHO) further added that “inappropriate use of traditional medicines
or practices can have negative or dangerous effects” and that “further research is needed to
ascertain the efficacy and safety. “The WHO director-general stated that “traditional medicines of
proven quality, safety and efficacy, contribute to the goal of ensuring that all people have access
to care.” Traditional medicine or herbal medicine is the main source of primary health care for
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millions of people all over the world, since it is more accessible and affordable than modern
medicine; sometimes it is found closer to home [19].
1.8 HERBAL MEDICINE:
Herbal medicine, also known as phytomedicine or botanical medicine, refers to plants
leaves, roots, seeds, bark, flowers or berries that are used for medicinal purposes. It is ending up
more standards, as upgrades in investigation and quality control, alongside with advances in
clinical research, demonstrate the value of herbal medication in the treating and forestalling
infection [20]. Dated back from the Sumerian civilization, hundreds of medicinal plants including
opium were found and recorded on clay tablets. 850 plant medicines are depicted by the Egyptian
Papyrus, while Dioscorides reported more than 600 therapeutic plants in De materia medica,
creating the premise of pharmacopoeias in the 1500. Medication with plants makes utilization of
ethnobotany to scan for pharmacologically active substance in nature and it has thusly found
several important and helpful compounds [21].
Botanicals are used to form almost one fourth of pharmaceutical medications. According
to World Health Organization, almost 80% of the world population rely on herbal medicine for
their primary health care. About 600 to 700 plant-based meds are accessible in Germany and are
endorsed by 70% of German doctors. From the past couple of decades, in United States, people
has prompted an expansion in herbal medication utilization, expansion that may be due to open
disappointment with the expenses of the prescribed drugs, as well as from enthusiasm for coming
back to natural or organic remedies [22].
Also, herbal medicine plays an important role in the treatment of kidney stones. It has been
used to inhibit the growth of kidney stones, to prevent the new formation of stones, and to break
the stones. According to the article by David Wainston, berberis vulgaris, nigella sativa,
11

phyllanthus niruri, oenothera biennis, trigonella foenum-graceum, hibiscus sabdariffa, lareea
tridentata, elymus repens, etc., are the mostly used plants for herbal remedies for kidney stone in
different countries like India, China. Other plants like viburnum prunifolium, viburnum opulus,
ammi visnaga, dioscorea villosa, and lobelia inglata are commonly recommended by naturopathic
doctors for help in passing kidney stone. However, an excessive use of these herbs may have
potential side effects [23].
Traditional Chinese medicine, native American medicine, eclectic/physio medical
medicine, European traditions, and Ayurveda have long history of using medical herbs to deal with
kidney stone and urinary calculi. Phyllanthus niruri is commonly used by natives of the tropics to
help decreasing urinary calcium levels in patients with hypercalciuria and to slow down the growth
of existing stones. Chinese herbs such as desmodium styracifolium significantly reduces formation
of renal stones by inhibiting urinary calcium excretion and increasing urinary citrate. Generally,
fenugreek seed (trigonella foenum-graecum) is used in North Africa to help preventing kidney
stones. Tribulus terrestris (gokshura fruit/root) is an Ayurvedic rasayana (nephroprotective agents)
that is mostly used in India and China to treat urinary tract diseases. Spanish herbal formula,
fagolitas, is composed of fluid extracts of uva ursi. Corn silk, ricinus zanzibarensis, tincture of
saw palmetto, and mother tincture of bachu glycerine and anise essence are given to animals to
reduce papillary and intratubular calcification in the kidney. In India, Ayurvedic herbs like
crataeva nurvala and asparagus racemosus are used to treat kidney stones. Traditional Chinese
medicine practices like Wu Ling San, Liu Wei Di Huang, and Shi Lin Tong are used for treating
dysuria, edema, and cystitis, and to help strengthening the kidneys. North African plant ammi
visnaga is an effective antispasmodic, useful for relieving spasm and pain in the urinary tract, gall
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bladder, respiratory tract, and cardiovascular system. It also helps to pass urinary calculi more
smoothly [24].
Thus, both traditional and modern medicines have been extensively studied to inhibit the
growth of urinary calculi in vivo. Nowadays, modern technology such as fiberoptic infrared
spectroscopy and CT scan are used to detect and analyze urinary calculi.
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Chapter 2: METHODOLOGY
2.1 RAMAN SPECTROSCOPY:
Named in the honor of its inventor Professor Sir CV Raman, Raman spectroscopy is an
analytical tool in material science that helps to analyze the characteristics of molecules, identify
them, and understand their properties based on the phenomenon of scattering of radiation from
vibrating molecules[25]. Raman spectroscopy is regularly utilized as a part of science to give an
auxiliary unique mark (structural fingerprints) by which materials can be distinguished[26].
The diagnostic flexibility of Raman atomic spectroscopic methods considers exploring a
wide variety of sample including solids, semi-solids, semiconductor, polymers, fullerenes, carbon
nanofiber, and other carbon-based materials[27]. It also includes the non-intrusive examination of
synthetic chemical reaction mixtures, biological samples and intermediates such as capsule,
powders, ointment, and heterogeneous suspensions with negligible or no sample preparations.
Raman spectroscopy resolves a large portion of constraints of other spectroscopic techniques, as
can be utilized for both, qualitative and quantitative analysis. Quantitative analysis can be
performed by estimating the intensity of scattered radiation, while the qualitative analysis can be
done by measuring the frequency of scattered radiation.
Raman spectrophotometric systems can be either dispersive or non-dispersive. Dispersive
Raman spectrophotometers utilize gratings

or prisms, while non-dispersive Raman

spectrophotometers make use of interferometer, such as Michelson interferometer in Fourier
transform Raman spectroscopy[25].
The Raman effect/scattering can be explained in two different approaches:
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2.1.1 CLASSICAL APPROACH:
The fundamentally essential condition for observing the Raman scattering is that the
polarizability must change during the vibrations of the molecules. Mathematically, this is
explained from the electromagnetic field strength E of the electromagnetic waves produced by the
laser, which depends on time t as follows:
𝐸 = 𝐸0 𝑐𝑜𝑠2𝜋𝑣0 𝑡

(1)

where 𝑣0 is the laser frequency and 𝐸0 is the vibrational amplitude. The induced electric dipole
moment P due to irradiation of diatomic molecule (say) by laser is given by:
𝑃 = 𝛼𝐸 = 𝐸0 𝑐𝑜𝑠2𝜋𝑣0 𝑡

(2)

where 𝛼 is a proportionality constant called polarizability. The displacement q due to the vibration
of the molecules can be written as:
𝑞 = 𝑞0 𝑐𝑜𝑠2𝜋𝑣𝑚 𝑡

(3)

where 𝑣𝑚 is the vibrational frequency of molecule and 𝑞0 is the vibrational amplitude. For a small
amplitude, 𝛼 is related with q by the formula:
𝑞 = 𝛼0 + (𝑑𝛼|𝑑𝑞)0 𝑞 + ⋯

(4)

where 𝛼0 is the value of polarizabilty at equilibrium position and (𝑑𝛼|𝑑𝑞) is the change in the
value of 𝛼 with change in q at equilibrium position.
Using the value of (1), (3), and (4) in equation (2) we get:
𝑃 = {𝛼0 + (𝑑𝛼|𝑑𝑞)0 𝑞 + ⋯ }𝐸0 𝑐𝑜𝑠2𝜋𝑣0 𝑡

(5)

Ignoring higher terms
𝑃 = 𝛼0 𝐸0 𝑐𝑜𝑠2𝜋𝑣0 𝑡 + (𝑑𝛼|𝑑𝑞)0 𝑞𝐸0 𝑐𝑜𝑠2𝜋𝑣0 𝑡
= 𝛼0 𝐸0 𝑐𝑜𝑠2𝜋𝑣0 𝑡 + (𝑑𝛼|𝑑𝑞)0 𝑞0 𝐸0 𝑐𝑜𝑠2𝜋𝑣𝑚 𝑡𝑐𝑜𝑠2𝜋𝑣0 𝑡
= 𝛼0 𝐸0 𝑐𝑜𝑠2𝜋𝑣0 𝑡 +

1
2

(𝑑𝛼|𝑑𝑞)0 𝑞0 𝐸0 [𝑐𝑜𝑠2𝜋(𝑣𝑚 + 𝑣0 ) + 𝑐𝑜𝑠2𝜋(𝑣𝑚 − 𝑣0 )]
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(6)

Here first term gives the oscillating dipole that radiates light of frequency 𝑣0 , i.e. Rayleigh
scattering. The second term gives Raman Scattering with anti-Stokes frequency (𝑣𝑚 + 𝑣0 ) and
Stokes frequency (𝑣𝑚 − 𝑣0 ). This relationship shows that for Raman Scattering to occur, the rate
of change in polarizability with the vibration of molecule is absolutely necessary[28].
2.1.2 QUANTUM APPROACH:
In Raman spectroscopy, monochromatic laser beam is allowed to incident the sample under
investigation, leading to scattering. A significant part of the light is scattered elastically (i.e.,
Rayleigh scattering), whereas a small portion of the light is scattered inelastically (i.e., Raman
effect). The inelastic scattering or Raman scattering occurs due to the change in vibrational,
rotational, or electronic energy of the excited molecules. This scattering provides a “structural
fingerprint” used for molecular identification. During this scattering, molecules absorb energy and
excite to higher energy vibrational state from their ground state. This is called Stokes scattering.
In a Raman spectrum, Stokes lines appear when the frequency of the incident beam is greater than
that of the scattered radiation frequency. With the release of energy, molecules transfer from the
higher energy state to the ground state. This process is called anti-Stokes scattering. Anti-Stokes
lines appear in a Raman spectrum at frequencies lower than that of the incident beam [29]. The
magnitude of the Raman shift does not rely on the wavelength of the incident beam.
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A schematic representation of the process is presented below:

Figure 2.1: Raman and Rayleigh scattering diagram showing a low energy (arrow upward) and a
scattered energy (arrow downward) [30].
2.2 EXPERIMENTAL SET UP FOR RAMAN SPECTROSCOPY:
For experimental measurements an alpha 300 WITec confocal Raman system was used.
The 523nm excitation of a Nd:YAG laser and a 20X objective were employed. The framework of
the Raman system in the Optical Spectroscopy & Microscopy Laboratory is shown below:

Figure 2.2: Display of the alpha 300 WITec confocal Raman system[31].
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2.3 CONFOCAL RAMAN SPECTROSCOPY:
The Harvard graduate Marvin Minsky is the first person to build confocal microscopy in
1955 and patent it in 1957. Confocal microscopy is an indispensable and powerful optical imaging
technique for spatial molecular mapping. Raman microscopy combines a Raman spectrometer to
a standard optical magnifying instrument, permitting high amplification perception of a sample
and Raman investigation with a minuscule laser spot[32].
Confocal Raman microscopy (CRM) imaging provides pictures with consistent microresolution in less amount of time. The magnitude of this kind of resolution is greater than of any
regular FTIR resolution. The data stored and processed in CRM’s digital Raman spectroscopy can
be used to diminish the effect of background-noise in the electronic system. As a result, trace
components can be precisely evaluated. Furthermore, since the energy of the laser can penetrate
the surface of a sample without destroying it, CRM can disclose Raman spectroscopic data from
subsurface layers. Thus, the confocal imaging system lets specific control of the depth where the
spectroscopic data is attained. This non-invasive depth measurement permits encrusted samples to
be examined without cutting cross-section[33].
The basic principle of confocal microscopy is shown in Figures 2.3 and 2.4. Unlike
conventional microscopy, where the entire sample is illuminated evenly with the light source, a
confocal microscope illuminates only a solitary point on a sample, by using a small pinhole
aperture refocused by microscope objective. The second pinhole aperture placed between the
microscope objective and the image plane reprobates the remaining scattered rays that came from
out-of-focus points on the sample and function as a spatial filter. The first pinhole aperture
enormously reduces scattered light and gigantically enhance the picture quality, while the second
aperture rejects out-of-focus planes that allows resolution in possible depth[34].
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Figure 2.3: Optical scheme of confocal spectroscopy [34].

Figure 2.4: Spatial filtering with a second pinhole aperture of the horizontal (a) and vertical (b)
out-of-focus rays [34].
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A schematic diagram of the beam path in the alpha 300 WITec system of the Optical
Spectroscopy & Microscopy Laboratory at UTEP is presented below, with appropriate label
explanations.

Figure 2.5: Schematic illustration of the beam path for the alpha 300 WITec confocal Raman
system.

Here, U1=XY positioner, U2= Scan stage, U3= Objective turret with objectives, U6= Binocular
tube with ocular camera, U8= Fiber coupling unit optical output, U9= Pushrod, U10= Filter Slider
Unit, U11= Laser coupling unit optical input, U14= Microscopic Z stage with stepper motor, M9=
Objective turret, M10= Reflector slider, E1= Multi-mode optical fiber, E2= Single-mode optical
fiber, E3= Laser, E4= Spectrometer
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2.4 FOURIER TRANSFORM INFRARED SPECTROSCOPY:
Fourier transform infrared spectroscopy (FTIR) is a commercially successful analysis
technique used in material characterization. Through a Fourier transform algorithm raw data are
converted into an actual spectrum. The information acquired from this procedure is unattainable
by many other spectroscopic techniques. It acquires high caliber and high-resolution data in a short
period of time to analyze complex mixture rapidly and precisely. The utilization of FTIR has
moved from research facilities to quality control laboratory, being used in relatively every
expository chemical laboratory[35].
2.4.1 WORKING MECHANISM OF FTIR:
FTIR is the consolidated utilization of infrared (IR) light to irradiate samples with an
interferometer. Through an interference pattern, an absorption spectrum characteristic of the
sample is recouped using a Fourier transformation algorithm. The most common interferometer
employed in such analysis is based on the Michelson interferometer, which is shown schematically
below:

Figure 2.6: Schematic diagram of Michelson interferometer [36].
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Michelson interferometer consists of two plane mirrors that are silver coated in the front
side; one fixed and another one movable. The beam splitter is made up of a plane glass plate and
a compensator material with same thickness. The beam splitter is placed vertically at an angle of
45 degree to the direction of the incident light.
The collimated beam of light is allowed to strike on the beam splitter; half of the incident
radiation is transmitted to a fixed mirror, and the other half is reflected to a movable mirror. These
two beams are reflected back from the mirrors to the beam splitter. Since they go through different
optical paths, an interference pattern form. The interference pattern obtained in FTIR comprises
of light having extensive range of frequencies, which include far-infrared, mid-infrared, and nearinfrared regions of electromagnetic spectrum. Since the sample absorbs the radiation just at
specific frequencies, the interference pattern changes the analyzed sample, subsequently delivering
the spectrum characteristic to the sample.
Then, the signal is transformed into an electric signal. At that point, an array processor
controls and manipulates the obtained data. The acquired signal is then converted using a fast
Fourier transform with the Cooley-Turkey algorithm. Manipulation of interferogram information
comprises of co-including successive scans that improves signal-to-noise ratio of a spectrum,
apodization, and phase correction to remove instrumental artifacts[37].
2.4.2 ADVANTAGES OF FTIR OVER OTHER SPECTROSCOPIC TECHNIQUES:
Some of the advantages of FTIR are:
• In a short time period, many scans can be completed and averaged on a FTIR.
• More energy is reached to the sample because of less reflective loss that improve signal-to-noise
ratio of FTIR. Improved signal-to-noise ratio provide higher sensitivity of the instrument for small
absorption resulting in clearer and more distinguishable spectrum.
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• Laser used in FTIR act as reference signal within the instrument that provide reference to both
precession and accuracy of the infrared spectroscopy [38].
2.4.3 EXPERIMENTAL SET UP FOR FTIR:
For the experiments in this work a vacuum-based Bruker IFS 66v Fourier Transform
Infrared (FTIR) interferometer was employed. This system is a Michelson type two-beam
interferometer with fundamental parts of collimating optics, a movable mirror and fixed mirror,
and a beam splitter. The defects produced due to mirror displacement is compensated by the
dynamical arrangement control system of the Bruker IFS 66v. The alignment of the interferometer
is maintained by control system using stabilized singe mode Helium-Neon (He-Ne) laser. The HeNe laser beam pursues indistinguishable optical path from the infrared light, however goes through
its own beam splitter.
The Bruker IFS 66v system and its schematic optical path are presented in the following
figures.

Figure 2.7: Bruker IFS 66v/S vacuum – based FT-IR system[39].
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Figure 2.8: Schematic diagram of Bruker IFS 66v optical path.
2.5 COMPARISON BETWEEN RAMAN AND FTIR SPECTROSCOPY:
Raman spectroscopy and FTIR vary in some key major factors. The fundamental contrast
between the two systems lies in the idea of molecular transitions occurring. Raman spectroscopy
is an inelastic scattering phenomenon that depends upon the change in polarizability of molecule
during vibration, whereas FTIR is a form of vibrational spectroscopy that depends on a change in
dipole moment. So, IR absorption lines cannot be observed if a molecule is symmetrical; typically,
it is hard to polarize a molecule with strong dipole moment. FTIR measures absolute frequencies,
whereas Raman spectroscopy measures relative frequencies during the absorption and scattering
of radiation by the sample. The basic advantage of Raman method over FTIR is that Raman method
requires none or too little sample preparation, whereas FTIR method has restriction on sample
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thickness, its consistency and dilution to dodge saturation. Fluorescence does not interfere with
the ability of taking FTIR spectra, which could be an issue with Raman Spectroscopy.
Regardless of their differences, the two techniques have points of interest and
confinements. However, when joined, these two strategies turn into an intense apparatus when
performing materials characterization. Molecules that cannot be detected with the one method can
be easily detected with the other, and that leads researchers to use them both, in a complementary
way[40][41].
2.6 SAMPLE PREPARATION:
The single diffusion gel growth technique is one of the most popular technique used for
growing calcium oxalate crystals in laboratory. This technique was employed to grow our samples.
The process to grow the crystal is similar to the ones reported by many other researchers. The
chemicals used to synthesize the crystals were purchased from Sigma-Aldrich, whereas Knox
gelatin was purchased from over the counter.
The overall process to grow the crystals using single gel diffusion technique is described
below:
-

the crystal needs to grow without and in the presence of various concentrations of NDGA
(nordihydroguaiaretic acid) solutions. Thus, different concentrations of NDGA were
prepared, namely of 25 μM, 50 μM, 75 μM, 100 μM, 250 μM, 500 μM, and 1 mM (1000
μM). These NGDA concentrations were sandwiched between the calcium chloride solution
and potassium oxalate solution. The layers, from bottom to top, are as follows:

1. Calcium chloride solution – aqueous solution of calcium chloride and Knox gelatin
2. NDGA solution – aqueous solutions of NDGA, at different concentrations for the 7
NDGA-containing samples
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3. Potassium oxalate solution – potassium oxalate and gelatin

2.6.1 PREPARATION OF STOCK SOLUTIONS:
The 0.4M stock solution of calcium chloride (CaCl2) was prepared by adding 8.8785g of
calcium chloride into 200 ml deionized water. This solution was stirred vigorously to dissolve.
𝑀 × 𝑀𝑢 × 𝑉 = (0.4

mol
g
) (110.98
) (0.2 L) = 8.8785 grams CaCl2
L
mol

8.848 g of Knox gelatin was added into the CaCl2 solution, stirred vigorously, and heated to
dissolve. This solution should not boil excessively, as this will destroy the gelatin. Poured 25 ml
of solution into each of the eight glass tubes and allowed to cool overnight at room temperature.
Similarly, the 0.4M stock solution of potassium oxalate monohydrate as made.
2.6.2 NDGA SOLUTIONS:
NDGA solutions at 7 different concentrations were made and pipetted over the set calcium
chloride gelatin in the glass tubes, at a volume of 0.3 ml—enough to create a thin layer of solution
in a ~2 cm diameter tube. The 7 concentrations are 25 μM, 50 μM, 75 μM, 100 μM, 250 μM, 500
μM, and 1 mM (1000 μM). One glass tube receives 0.3 ml water (no NDGA), and serves as the
control.
2.6.3 GENERAL ARRANGEMENT OF SAMPLES ASSEMBLY:
Firstly, the stock solution of calcium chloride was placed at the bottom of the eight glass
tubes. Then, the seven different concentrations of NDGA solutions were placed gently on top of
each tubes containing calcium chloride solution. The remaining one tube had just 0.3ml water
instead of NDGA. 25 ml of the potassium oxalate gelatin solution was added gently to each tube,
layering it over the calcium chloride and NDGA layers using a spoon to deflect the force of the
stream and reduce turbulence. The schematic representation of some of the sample is shown below:
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Figure 2.9: The schematic representation of some of the sample.
Then, the beaker was covered tightly with aluminum foil and allowed to go diffusion process.
After a month or so, the crystals were formed and then harvested and analyzed.
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Chapter 3: EXPERIMENTAL RESULTS AND DISCUSSION
3.1 INTRODUCTORY REMARKS:
There are several scientific reviews highlighting the structural composition of kidney
stones. For example, Xiaoyu Chi et al. used microscopic Raman spectroscopy to analyze and
classify the kidney stones and the present minerals. The experimental Raman spectra of kidney
stones showed high classification accuracy and this approach can provide detail treatment
recommendations to patients with kidney stones [42]. The research group led by Venkata Ramana
Kodati et al. used the Raman scattering technique to obtain spectra from four different kidney
stones. They used argon-ion laser on the surface of stones and found that three stones are basically
composed of hydrates of calcium oxalate. They compared and examined the scattered Raman shift
with that of standard hydrates and found that spectra of two stones are almost identical to calcium
oxalate monohydrate with the characteristics band 1465 cm-1 and 1492 cm-1. The third stone has a
band of 1477 cm-1 which shows the characteristics of COD but showing weaker bands at 1465 and
1492 cm-1 which are seen in the spectra of COM. It has been concluded from this experiment that
the Raman analysis can be used not only to identify the components but can be used to show the
relative distribution within the stone[43].
The research done by V.B Suryawanshi et al. recorded FTIR spectra of various vibrational
modes from synthetically prepared calcium monohydrate. He observed a strong band at 3423.76
cm-1 and 3057.27 cm-1 in the spectrum which is due to asymmetric and symmetric stretching of
OH and a band at 3244.38cm-1 shows intermolecular hydrogen bonded OH stretch. At 1618.33
cm-1 and 1315.50 cm-1, Intense absorption band are observed which is due to asymmetric and
symmetric C=O stretching bands specific to the COM. The occurrence of oxalate group in COM
is confirmed due to presence of the sharp band at 883.43 cm-1 by C-C stretching vibrations.
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Because of bending and shaking modes of the water molecule, the sharp peak at 777.34 cm-1 due
to O-C=O and the wide bands at 663.53 cm-1 are observed. Thus, the FTIR spectroscopy
established the development of COM crystals are due to the occurrence of water of
crystallization[44].
The research group of D Valarmathi used Brucker IFS 66 V FTIR spectrometer to analyze
the IR spectrum of synthetically prepared COM crystal. He observed the band at 1615cm -1 and
1319 cm-1 which are assigned to C=O stretching and the band at 1069 cm-1 and 1000 cm-1 to C-O
stretching that confirm the existence of carboxylate anion in COM crystal. The presence of two
carboxylate anion is assigned by the band at 865 cm-1 that specifies C-C stretching which in turn
confirms the occurrence of oxalate group in COM crystal[45].
Apart from standard Raman and FTIR, confocal Raman mapping can be used to imaging
and analyzing from chemical perspectives the urinary stone. These methods help in providing two
dimensional maps of the constituents’ distribution in the samples. Vincent Castiglione et al. took
fourteen calculi and analyzed them chemically by confocal Raman imaging. A confocal Raman
microspectrophotometer was used. This approach successfully detected the chemical composition
of each sample including calcium oxalate monohydrate and dihydrate, anhydrous and dihydrate
uric acid, apatite, struvite, brushite, and rare chemicals like whitlockite, ammonium urate and
drugs. It has been concluded that imaging technique provides a good accuracy in comparison with
infrared spectroscopy in identifying components of kidney stones. The analysis was also valuable
in providing the group of components within stones, which help tracing constituents in low
quantity, such as nuclei. However, this type of investigation is long and time consuming, making
it more suitable for research studies rather than routine analysis[46].
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Nowadays, a large amount of research focuses on spectroscopic study with the infusion of
herbal extract to treat kidney stones. Joshi et al. used herbal extracts of Tribulus terrestris and
Bergenia ligulate to inhibit the growth of kidney stones. Initially, calcium oxalate monohydrate
crystals were grown by a double diffusion gel growth technique. They were prepared in a hydrated
sodium metasilicate solution and nutrients were provided for the growth. Tribulus terrestris and
Bergenia ligulata were generally used as herbal medicines for urinary calculi in India. In order to
verify the inhibition effects of this herbal plant, herbal extract was added to the supernatant
solutions. The growth was analyzed with and without the herbal extracts[47].
Manciu et al. spectroscopically demonstrated in two peer-reviewed articles the use of
herbal plants, namely Larrea Tridentata and Rotula Aquatica Lour in inhibition of kidney stone
formation

[48].

Larrea

Tridentata

contains

several

lignans

including

antioxidant

nordihydroguaiaretic acid (NDGA) that interact with calcium oxalate kidney stone. It has been
found that the antioxidant NDGA inhibit the intercellular movement of transporters and protein
synthesis which can limit the nucleation of calcium oxalate monohydrate [49].
3.2 RAMAN ANALYSIS OF KIDNEY STONES:
Raman spectroscopy analyze, characterize and conclusively identify the types of kidney
stone present in the sample. In this method, samples are illuminated using laser and it uses a
characteristic spectrum in the visible wavelength range of the examined sample called a chemical
fingerprint. About 1% of the photons are reflected back in a different wave spectrum highly
specific to the sample and these signals are recorded in a database. Then, the fluorescent
background occurring during Raman spectroscopy are filtered out using computer software.
This method works on wet, unprepared samples and substantially reduced the time to prepare the
sample. A unique feature of the system is its spectral database[50].
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Raman spectroscopic studies of the calcium oxalate helps to distinguish between their
hydrate form. Basically, their present two types of calcium oxalate i.e. calcium oxalate
monohydrate(whewellite) and calcium oxalate dihydrate(weddellite) with varying in proportion
and is very difficult to examine if either of the component is in excess. For highly pure whewellite
calculus, the occurrence of whewellite is detected by a high-frequency shoulder of the sharp band
at 1315cm-1. While, for nearly pure weddellite calculus, whewellite can be detected by a
sharpening and increase in the relative intensity of the 780 cm-1 band and the detection of
characteristic bands of whewellite at 3492, 3430, 3058, 952, 885 and 665 cm-1. The sharp and
intense peak of the monohydrate is at 1493/1468 cm-1 doublet probably due to symmetric oxalate
anion stretch, while the less intense band at 1632 cm-1 may be due to asymmetric oxalate ion. The
spectral band at 898 cm-1 is due to C-C stretch. While, calcium oxalate dihydrate shows sharp
single spectral at 1477 cm-1 band and shifted C-C at 915 cm-1[51].

Figure 3.1: Raman spectra of calcium oxalate monohydrate and calcium oxalate dihydrate
simultaneously[51].
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3.3 NORDIHYDROGUAIARETIC ACID (NDGA):
Nordihydroguaiaretic acid is a phenolic antioxidant compound found in the leaves and
twigs of the perennial desert bush, Larrea tridentata (creosote shrubbery). It has a long history of
conventional therapeutic use by the Native Americans and Mexicans. It is also known as
gobernadora in Mexico and chaparral in USA. Chaparral tea has been used as conventional
medicine to treat different medical issues like diabetes, infertility, tuberculosis, kidney and gall
bladder stones, pain and inflammation and arthritis. NDGA has been distinguished as one of the
conceivable instruments of its chemopreventive effect. Chemoprevention is one of the many
preferred existing tactics applied to ameliorate the occurrence of skin cancer[52]. A schematic
chemical representation of NDGA is shown in the figure 3.2 below.

Figure 3.2: Chemical representation of NDGA structure [52].

This chemical compound has numerous health benefits. For example, the research study in
1986 showed that the feeding of NDGA to female mosquito increased its average life span from
29 days to 45 days which is 50% increment[53]. The research conducted in 2008 concluded that
the life span of male mice increased with the use of NDGA but not for female mice[54]. Though,
it has been used as nutritional supplement; it is found that the chronic use of NDGA or Larrea
tridentata cause renal toxicity and hepatotoxicity[55].
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3.4 EXPERIMENTAL RAMAN RESULTS:
Recently, researchers are using single diffusion gel technique to grow calcium oxalate
crystals, also known as kidney stones in the lab. Numerous methods are presented for the growth
of calcium oxalate in gelatin and silica gels under different conditions. We used knox gelatin as
the gel medium to grow such calcium oxalate crystallites, since this medium allows the growth
process to be controlled by stereospecificity. The calcium oxalate monohydrate crystals can have
shapes of splices, twins, spherulites and dendrites [56].
Thus, in the current study, the crystals were synthetically grown by the gel diffusion
technique, as described before. Representative pictures showing the different concentrations of
NDGA sandwiching between potassium oxalate and calcium chloride in a gel medium.

Figure 3.3: Image of nucleation process of calcium oxalate crystals grown with different
concentrations of NGDA, as labeled.
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Crystals without and with addition of NDGA at different concentrations were harvested
after a month and visually analyzed for their shapes and sizes. Later on, the samples were analyzed
using Raman spectroscopy and Fourier transform infrared (FTIR) spectroscopy. Such
measurements were done at the different spots on the crystals. As gelatin is used to prepare the
crystals, some of the gelatin is embedded with the crystal. It has been made sure that only the
crystalline part was used for measurements under Raman and FTIR. Some images of the harvested
crystals are shown below.

a

e

b

f

c

d

g

h

Figure 3.4: Calcium oxalate crystals grown: a) without the NDGA concentration (b) to (h) with
different concentrations of NDGA.

Under the optical microscope it was found that without the NDGA the crystals have a
smooth spherical surface and with addition of NDGA agglomerates with different shapes occur.
Also, with the increase in concentration of NDGA the overall size of these agglomerates decreases.
These observations were obtained by analyzing the small crystallites under the microscope.
34

Generally, calcium oxalate has two forms: calcium oxalate monohydrate (COM) and
calcium oxalate dihydrate (COD), as seen below in Figure 3.5. Basically, these two components
are same as both have two carbon atoms and one calcium atom but are different in the amount of
water molecule. Calcium oxalate dihydrate is associated with two molecules of water whereas
calcium oxalate monohydrate has one molecule of water associated with it.

Figure 3.5: Molecular structure of COM[57] and COD[58], respectively.

These two phases of calcium oxalates are differentiated with the use of Raman
spectroscopy, as can be observed in Figure 3.1. Raman spectroscopy is a very convenient and
suitable method that helps to find the structure of materials and arrangement of the molecules.
Comparison of Figure 3.1 with Figure 3.6, where the Raman results for the currently synthesized
calcium oxalate crystals is presented, shows that these crystals exhibit a COM structure.

Figure 3.6: Raman spectrum of standard calcium oxalate crystals showing a COM structure.
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In both spectra the doublet peaks in the 1200-1600 cm-1 region is observed which is characteristic
to COM structure. Other Raman features around 500 cm-1 and 900 cm-1 are also common in both
spectra.
The comparative of Raman spectra of calcium oxalate crystals growth with or without
NDGA concentrations are shown in the figure 3.7. These spectra display a similar structure as for
that of the control sample. Thus, the use of different concentrations of NDGA do not contribute to
a structural modification from COM to COD. The Raman spectrum of COM without the presence
of NDGA shows doublet peaks around 1465 cm-1 and 1492 cm-1 region, which is due to symmetric
oxalate anion stretch, while the less intense band at 1632 cm-1 is due to asymmetric oxalate ion.
The spectral band at 898 cm-1 is due to C-C stretch. On the other hand, calcium oxalate dihydrate
shows sharp single spectral at 1477 cm-1 band and the vibrational line attributed to C-C is shifted
at 915 cm-1. Thus, with NDGA addition, all the crystals have a COM structure, as revealed by
these Raman spectra.
Furthermore, comparison of figure 3.7 with figure 3.8, where the NDGA Raman spectrum
is presented, demonstrates no detection of this compound in the crystals grown with NDGA, not
even for the highest NDGA concentration.
A closer look at these Raman spectra, which is presented in figure 3.9, shows that the
intensity of second peak around 1492 cm-1 slightly decreases with the increase in the concentration
of NDGA. It is seen that the NDGA has an effect on the growth of calcium oxalate crystal. As
explained above, these two vibrational lines that form doublets are expected to symmetrical
carbonyl COO- modes, and their intensities are related with the lengths and strength of C-C bond
of COM structure. It is realized that COM contains both planar and twist oxalate units, with shorter
C-C bonds in the contorted units than in the planar ones. In this manner, as NDGA concentration
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increases, the distinction in the C-C bonds lengths become bigger, and, therefore, their strength as
well. Explicitly, the C-C bonds in the contorted units change lengths in the stones developed with
NDGA.

Figure 3.7: Raman spectra of crystals grown without and with 25µM, 50 µM, 75 µM, 100 µM,
250 µM, 500 µM, 1mM NDGA inhibitor, as labelled, in the region of 50-3700 cm-1.

37

Figure 3.8: Raman spectrum of NDGA.

Figure 3.10 shows the Raman spectra of the crystals grown without and with NDGA in the
low frequency region of 100 cm-1 to 1300 cm-1. These spectra show again no sign of NDGA, not
even for the most intense vibrational lines of this compound around 800 cm-1. Also, as previously
mentioned these vibrational Raman spectra are similar to that of pure calcium oxalate crystals. A
few other vibrational changes can be seen in this figure, such as decreases in the intensities of 200
and 500 cm-1 features, demonstrating again the effect of NDGA in the crystal morphology. The
Raman feature around 500 cm-1 consists of many peaks; thus, with NDGA, the 526 cm-1 vibrational
line is seeming to increase in intensity, whereas the intensity of the peak at 503 cm-1 is decreasing.
However, no definite pattern is observed.
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Figure 3.9: Raman spectra of crystals with 25µM, 50µM, 75 µM, 100 µM, 250 µM, 500 µM and
1mM NDGA inhibitor, as labelled, for the frequency range 1250-1800 cm-1.
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Figure 3.10: Raman spectra of crystals without and with 25µM, 50µM, 75 µM, 100 µM, 250
µM, 500 µM and 1mM NDGA inhibitor, as labelled, for the low frequency range of 100-1300
cm-1.
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3.5 INFRARED ABSORPTION RESULTS:
Fourier transform infrared (FTIR) spectroscopy is used to obtain other complementary
information regarding changes in the morphology of calcium oxalate crystals due to the presence
of NDGA. Infrared results of the crystals are presented and analyzed below in two different
spectral regions: the 1000-2500 cm-1 region and the 2400-4000 cm-1 region. A first comparative
FTIR results of calcium oxalate crystals with and without NDGA concentrations in the first region
is shown in figures 3.11 and 3.12. For easier visualization, the graphs are separated in two figures.

Figure 3.11: Infrared absorption spectra of crystals without and with 25 µM, 50 µM, and 75 µM
NDGA inhibitor and the spectrum of the NDGA alone, as labeled, for the frequency range 1000 –
2500 cm-1 [48].
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Figure 3.12: Infrared absorption spectra of crystals without and with 100 µM, 250 µM, 500 µM
and 1 mM NDGA inhibitor and the spectrum of the NDGA alone, as labeled, for the frequency
range 1000 – 2500 cm-1 [48].

It can be seen clearly from these graphs that the spectral lines due to NDGA are dominant
in the region from 1000-2500 cm-1, overlapping with those corresponding to the crystals. However,
with increasing NDGA concentration, the sharp vibrational line at 1618 cm-1 is visible and its
intensity is increasing. Thus, besides the fact that all the spectra of the crystals grown with NDGA
resemble that of the spectrum of pure calcium oxalate crystals, it can be directly evidenced the
existence of NDGA in the samples.
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The infrared absorption spectra in the frequency region of 2400-4000 cm-1 are presented
below in figures 3.13 and 3.14. Again all the crystals have the CaOx morphology, namely that of
monohydrate. Furthermore, there is no evidence of NDGA in the structure of the crystals, although
the NDGA spectrum has a few characteristic non-overlapping vibrations in the 2800-3000 cm-1
region.

Figure 3.13: Infrared absorption spectra of crystals without and with 25 µM, 50 µM, and 75 µM
NDGA inhibitor and the spectrum of the NDGA alone, as labeled, for the frequency range 24004000 cm-1 [48].
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Figure 3.14: Infrared absorption spectra of crystals without and with 100 µM, 250 µM, 500 µM,
and 1 mM NDGA inhibitor and the spectrum of the NDGA alone, as labeled, for the frequency
range 2400-4000 cm-1 [48].
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Chapter 4: CONCLUSIONS
There are several causes that result in kidney stone. Acidic environment, lack of water in
the body, human diet, medical condition such as urinary tract infection, crohn’s diseases,
hyperparathyroidism, and genetic disorder increase the risk of kidney stone. Traditional medicine
that is an approach used to prevent kidney stone formation. Larrea Tridentata is one of the
traditional herbs that has been used in a tea form from generations for such prevention. Locally,
this plant is also known as Gobernadora and Chaparral. The flowers and leaves of this herb have
the highest concentration of the chemical compound known as nordihydroguaiaretic acid (NDGA).
This chemical compound is an antioxidant that can be used to treat several medical conditions.
In a spectroscopic study, Manciu et al. used Larrea Tridentata infusion as a natural extract
to evaluate its influence on kidney stone inhibition[59]. The crystals were synthesized without and
with Larrea Tridentata infusion by single diffusion gel technique. The harvested calculi were
analyzed with Raman spectroscopy, infrared absorption spectroscopy, and optical microscopy. It
was observed that the growth of calcium oxalate crystals decreased with increased amount of
Larrea Tridentata herbal infusion. Also, Raman and infrared spectroscopic analysis of calculi
showed the conversion of the structure of pure calcium oxalate crystals from monohydrate to
dehydrate. The outcomes of this investigation suggested that the inhibition mechanism may be due
to the binding of magnesium from the infusion with the carbonyl sites of calcium oxalate crystal.
As NDGA is the most important chemical compound found in the Larrea Tridentata, it can be
suggested that this chemical may have effect in the inhibition process of calcium oxalate crystals.
Thus, the current research is an attempt to confirm whether NDGA is the main cause of the
inhibition mechanism through a detailed study of the compound influence on synthetically grown
calcium oxalate kidney stones.
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The crystals are synthesized without and with different concentrations of NDGA by
employing gel diffusion technique. Different concentrations of NDGA, namely 25µM, 50µM,
75µM, 100µM, 250µM, 500µM, and 1mM were used. The harvested crystals were sonicated,
dried, and analyzed using Raman and FTIR spectroscopies.
Raman spectroscopic result suggested that the presence of NDGA in calcium oxalate
crystals has no contribution to the previously seen morphological change from COM to COD. The
presence of a doublet peaks around 1465 cm-1 and 1492 cm-1 region in the current Raman spectra
indicates a COM structure. These two vibrational lines are due to the symmetrical carbonyl COOmodes of calcium oxalate, and their intensities are related with the lengths and strength of the CC bonds of COM structure. With an increase in the concentration of NDGA, the intensity of the
second peak around 1492 cm-1 slightly decreases, demonstrating the effect of NDGA. Explicitly,
the C-C bonds change lengths in the stones developed with NDGA.
FTIR results reveal that the absorption line around 1618 cm-1 might be attributed to the
presence of NDGA in the crystals; with increasing NDGA concentration, the intensity of this
vibrational line increases. All the spectra of the crystals grown with NDGA resemble that of the
spectrum of pure calcium oxalate crystals, corroborating the Raman results.
From the current study, we concluded that although the presence of NDGA has an effect
in the inhibition mechanism of calcium oxalate crystals, it has no contribution in the previously
observed morphological change from a COM to a COD structure. With or without the presence of
NDGA, all the crystals have a COM structure.
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